It is devastating for parents of a newborn to learn that their child has a genetic disorder. At least the parents of one such child, Gideon Griffiths, a 5-year-old from
5-year-old receives first dose of treatment for Duchenne Muscular Dystrophygene therapy developed at Nationwide Children’s Hospital COLUMBUS – In a landmar
In a landmark moment for the Abigail Wexner Research Institute at Nationwide Children's, a 5-year-old from Bellefontaine, Ohio, received the first dose of a recently approved gene therapy for Duchenne muscular dystrophy at Nationwide Children's Hospital, where the therapy was invented and initially tested.